Dipeptidyl peptidase 4 (DPP-4) inhibitors

DPP4INH

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC A10BG

3476

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

2684

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

2684

diagram downward connector

Include endpoints None

2684

diagram downward connector
DPP4INH

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
?
Number of individuals
2604 1077 1527
?
Unadjusted prevalence (%)
0.84 0.62 1.13
?
Mean age at first event (years)
59.85 58.91 60.50

?
Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.00 [1.37, 2.91] 3.2e-4 326
15 years 0.01 1.59 [1.09, 2.30] 1.5e-2 236
5 years 0.00 2.11 [1.50, 2.95] 1.4e-5 79
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: DPP4INH – Dipeptidyl peptidase 4 (DPP-4) inhibitors
GWS hits:

Survival analyses between endpoints

Plot

before Dipeptidyl peptidase 4 (DPP-4) inhibitors
after Dipeptidyl peptidase 4 (DPP-4) inhibitors

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Dipeptidyl peptidase 4 (DPP-4) inhibitors